SRPT vs STRO
Sarepta Therapeutics Inc (SRPT) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
SRPT currently screens at market cap $2.34B. STRO currently screens at market cap $470.8M.
Not investment advice. Open the SRPT and STRO stock pages for the full models.
Not investment advice.